Malaria Vaccine Market Growth, Demand, Outlook, Report 2022-2030

The global malaria vaccine market size is expected to exhibit a CAGR of around 34% during 2022-2030. IMARC Group, a leading market research company, has recently releases report titled “Malaria Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global malaria vaccine market growth, share, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Malaria is an illness typically caused by the plasmodium parasite, which is transmitted to humans through mosquito bites. It manifests with common symptoms like fatigue, nausea, fever, headaches, and chills. The malaria vaccine is designed to trigger the production of antibodies, reducing the likelihood of contracting the disease. It can be administered through subcutaneous, intramuscular, or intradermal injections. The malaria vaccine can be broadly classified into three types: erythrocytic vaccine, pre-erythrocytic vaccine, and multi-antigen vaccine.

Request a Free PDF Sample for more detailed market insights:

Malaria Vaccine Market Trends and Drivers: 

The growing prevalence of malaria, particularly across tropical countries, is primarily driving the malaria vaccine market. Additionally, the launch of favorable policies by government bodies to spread awareness regarding disease prevention, as well as the importance of immunization among consumers, especially in the endemic and rural regions, is further catalyzing the market growth. Besides this, the inflating popularity of pre-erythrocytic vaccines, also known as anti-infective vaccines, that target the plasmodium parasite and prevent progression to chronic blood-stage diseases is acting as another significant growth-inducing factor.

Moreover, numerous pharmaceutical companies are focusing on the development of improved and novel malaria vaccines by increasing the clinical trials of several pipeline drugs, which is positively influencing the global market. Apart from this, continuous technological advancements, such as the introduction of novel adjuvants and cutting-edge delivery platforms, extensive R&D activities, and the increasing investments in healthcare infrastructures, are anticipated to fuel the malaria vaccine market over the forecasted period.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

Malaria Vaccine Market Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Type:

  • Pre-Erythrocytic Vaccine
  • Erythrocytic Vaccine
  • Multi-Antigen Vaccine
  • Others

Breakup by Agent:

  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Anopheles Species

Breakup by Route of Administration:

  • Intramuscular
  • Subcutaneous
  • Intradermal
  • Others

Breakup by Distribution Channel:

  • NGO/Non-Profit Organization
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800


Follow us on Twitter: @imarcglobal


Health & Personal Care

Leave a Reply

Your email address will not be published. Required fields are marked *